Mimedx (MDXG) Prepaid Assets (2010 - 2026)
Mimedx recorded quarterly Prepaid Assets of $8.3 million in Q1 2026, down 19.53% quarter-over-quarter from $10.3 million in Q4 2025, and up 54.94% year-over-year from $5.4 million in Q1 2025.
Mimedx's Prepaid Assets history runs 17 years deep, the most recent figure standing at $8.3 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 54.94% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (up 54.94% YoY), while the FY2025 annual figure was $10.3 million, up 31.5% from the prior year.
- Prepaid Assets came in at $8.3 million for Q1 2026 at Mimedx, down from $10.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $10.3 million in Q4 2025 to a low of $2.6 million in Q1 2022.
- A 5-year average of $4.9 million and a median of $4.1 million in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets surged 444.07% in 2022 and sank 68.26% in 2024, its largest moves.
- Mimedx's Prepaid Assets stood at $3.3 million in 2022, then jumped by 68.64% to $5.6 million in 2023, then jumped by 39.31% to $7.8 million in 2024, then soared by 31.5% to $10.3 million in 2025, then retreated by 19.53% to $8.3 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $8.3 million, $10.3 million, and $4.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.29 Mn |
| Dec 31, 2025 | 10.30 Mn |
| Sep 30, 2025 | 4.25 Mn |
| Jun 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 5.35 Mn |
| Dec 31, 2024 | 7.84 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 4.03 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Dec 31, 2023 | 5.62 Mn |
| Sep 30, 2023 | 2.95 Mn |
| Jun 30, 2023 | 3.11 Mn |
| Mar 31, 2023 | 8.82 Mn |
| Dec 31, 2022 | 3.34 Mn |
| Sep 30, 2022 | 4.68 Mn |
| Jun 30, 2022 | 4.09 Mn |
| Mar 31, 2022 | 2.57 Mn |
| Dec 31, 2021 | 2.81 Mn |
| Sep 30, 2021 | 860,000.00 |
| Jun 30, 2021 | 1.82 Mn |
| Mar 31, 2021 | 4.70 Mn |
| Dec 31, 2020 | 5.61 Mn |
| Sep 30, 2020 | 5.47 Mn |
| Jun 30, 2020 | 5.19 Mn |
| Mar 31, 2020 | 5.22 Mn |
| Dec 31, 2019 | 6.06 Mn |
| Sep 30, 2019 | 3.74 Mn |
| Jun 30, 2019 | 2.55 Mn |
| Mar 31, 2019 | 4.62 Mn |
| Dec 31, 2018 | 6.67 Mn |
| Dec 31, 2017 | 9.02 Mn |
| Sep 30, 2017 | 6.66 Mn |
| Jun 30, 2017 | 1.02 Mn |
| Mar 31, 2017 | 6.88 Mn |
| Dec 31, 2016 | 1.84 Mn |
| Sep 30, 2016 | 6.21 Mn |
| Jun 30, 2016 | 5.97 Mn |
| Mar 31, 2016 | 5.77 Mn |
| Dec 31, 2015 | 3.39 Mn |
| Sep 30, 2015 | 2.74 Mn |
| Jun 30, 2015 | 2.65 Mn |
| Mar 31, 2015 | 2.34 Mn |
| Dec 31, 2014 | 1.54 Mn |
| Sep 30, 2014 | 1.97 Mn |
| Jun 30, 2014 | 2.33 Mn |
| Mar 31, 2014 | 2.28 Mn |
| Dec 31, 2013 | 1.34 Mn |
| Sep 30, 2013 | 1.54 Mn |
| Jun 30, 2013 | 1.35 Mn |
| Mar 31, 2013 | 1.19 Mn |
| Dec 31, 2012 | 657,961.00 |
| Sep 30, 2012 | 546,715.00 |
| Jun 30, 2012 | 292,223.00 |
| Mar 31, 2012 | 377,495.00 |
| Dec 31, 2011 | 164,664.00 |
| Sep 30, 2011 | 254,694.00 |
| Jun 30, 2011 | 234,192.00 |
| Dec 31, 2010 | 90,946.00 |